Cardiovascular Deaths in Pregnancy: Growing Concerns and Preventive Strategies

Anish Keepanasseril1, Birgit Pfaller2, Amy Metcalfe3

  • 1Department of Obstetrics and Gynaecology, Jawaharlal Institute of Post-graduate Medical Education and Research, Puducherry, India.

Insights

Maternal deaths from cardiovascular disease are rising globally. Improving awareness and care for heart conditions during pregnancy is crucial to prevent preventable deaths and improve outcomes.

Area of Science:

  • Cardiology
  • Obstetrics and Gynecology
  • Public Health

Background:

  • Cardiovascular disease (CVD) is a leading cause of maternal mortality worldwide.
  • In high-income countries, cardiomyopathies, ischemic heart disease, and aortic dissection are major causes of CVD-related maternal deaths.
  • Rheumatic heart disease remains a significant cause of maternal cardiac mortality in low- and middle-income countries.

Purpose of the Study:

  • To review the trends in maternal mortality and morbidity due to cardiovascular disease globally.
  • To highlight the diverse range of cardiovascular conditions affecting pregnant individuals, including pre-existing and new-onset conditions.
  • To discuss strategies for improving outcomes and addressing the knowledge gap among healthcare professionals.

Main Methods:

  • This is a review article, synthesizing existing literature on maternal cardiovascular mortality and morbidity.
  • The review examines data from both high-income and low- and middle-income countries.
  • It discusses various cardiovascular conditions and risk factors relevant to pregnancy.

Main Results:

  • Maternal deaths and serious cardiac morbidity ('near misses') from cardiovascular causes are increasing globally.
  • Both known and undiagnosed heart conditions, as well as new-onset cardiovascular issues like preeclampsia and peripartum cardiomyopathy, contribute to mortality.
  • A significant contributing factor to preventable deaths is the lack of awareness among healthcare professionals.

Conclusions:

  • Cardiovascular disease poses a significant and growing threat to maternal health worldwide.
  • Addressing the rising rates of maternal cardiovascular mortality requires increased awareness and improved clinical management.
  • Implementing targeted strategies and education is essential to reduce preventable maternal deaths and improve cardiac care during pregnancy.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
401
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
66
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
787
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.5K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
502
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.2K